IScanOr
Skin Screening Device for Early Detection of Cancer
Health Tech & Life Sciences
Non Active, Mar 2022 ceased to operate
Company Overview
Snapshot
Founded in October 2018 by Galit Ankri-Eliahoo and Oren Aharon, IScanOr operates with 1–10 employees. The company ceased operations in March 2022.
Business overview
IScanOr is developing an electronic skin-screening device designed for the early detection of skin cancer. This device aims to support medical staff in monitoring patients' skin and moles, leveraging photonics, optics technologies, sensors, image and data analysis, and AI algorithms to enhance accuracy. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Decision Support.
Company Intelligence Q&A
- What is IScanOr's primary focus?
- IScanOr is developing an electronic skin-screening device for the early detection of skin cancer, intended to assist medical professionals in monitoring patients' skin and moles.
- When was IScanOr founded?
- IScanOr was founded in October 2018.
- What technologies does IScanOr utilize?
- IScanOr's device is based on photonics and optics technologies, sensors, image and data analysis, and AI algorithms to improve detection accuracy.
- Who are the founders of IScanOr?
- ISCanOr was co-founded by Galit Ankri-Eliahoo and Oren Aharon.
- What is the current operational status of IScanOr?
- ISCanOr ceased to operate in March 2022.